These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30236853)

  • 1. Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors.
    Nettey OS; Walker AJ; Keeter MK; Singal A; Nugooru A; Martin IK; Ruden M; Gogana P; Dixon MA; Osuma T; Hollowell CMP; Sharifi R; Sekosan M; Yang X; Catalona WJ; Kajdacsy-Balla A; Macias V; Kittles RA; Murphy AB
    Urol Oncol; 2018 Nov; 36(11):501.e1-501.e8. PubMed ID: 30236853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between exercise and primary incidence of prostate cancer: does race matter?
    Singh AA; Jones LW; Antonelli JA; Gerber L; Calloway EE; Shuler KH; Freedland SJ; Grant DJ; Hoyo C; Bañez LL
    Cancer; 2013 Apr; 119(7):1338-43. PubMed ID: 23401030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients.
    Porter CR; Kim J
    Urology; 2004 Jan; 63(1):90-4. PubMed ID: 14751356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 men.
    Latchamsetty KC; Kim J; Porter CR
    J Urol; 2006 Mar; 175(3 Pt 1):913-7; discussion 917. PubMed ID: 16469578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
    Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R
    Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Yanke BV; Carver BS; Bianco FJ; Simoneaux WJ; Venable DD; Powell IJ; Eastham JA
    BJU Int; 2006 Oct; 98(4):783-7. PubMed ID: 16978273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening between low-income African-American and Caucasian men.
    Fowke JH; Schlundt D; Signorello LB; Ukoli FA; Blot WJ
    Urol Oncol; 2005; 23(5):333-40. PubMed ID: 16144667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
    Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
    J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
    Fowler JE; Bigler SA; Farabaugh PB
    Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
    J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.
    Vijayakumar S; Winter K; Sause W; Gallagher MJ; Michalski J; Roach M; Porter A; Bondy M
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):17-25. PubMed ID: 9422553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml.
    Fowler JE JR; Bigler SA; Farabaugh PB; Wilson SS
    J Urol; 2000 Dec; 164(6):1961-3. PubMed ID: 11061891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
    Jenkins KR; Oyekunle T; Howard LE; Wiggins EK; Freedland SJ; Allott EH
    Cancer Causes Control; 2021 Apr; 32(4):337-346. PubMed ID: 33532986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
    Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
    Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.
    Gaines AR; Turner EL; Moorman PG; Freedland SJ; Keto CJ; McPhail ME; Grant DJ; Vidal AC; Hoyo C
    Cancer Causes Control; 2014 Aug; 25(8):1029-35. PubMed ID: 24879044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.